Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells

Journal of Controlled Release

Volumn 91, Issue 1-2, 2003, Pages 53-59

  Nori, Aparna ^a   Jensen, Keith D ^a   Tijerina, Monica ^a   Kopečková, Pavla ^a,b   Kopeček, Jindřich ^a,b  

^a CCCD   (United States)

^b Department of Electrical and Computer Engineering   (United States)

Author keywords

Confocal microscopy; Subcellular fractionation; Tat peptide; Water soluble polymers

Indexed keywords

COPOLYMERS; CYTOLOGY; FRACTIONATION; MACROMOLECULES; TRANSPORT PROPERTIES; TUMORS;

INTRACELLULAR DRUG DELIVERY;

CONTROLLED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER DOXORUBICIN TRANSACTIVATOR PROTEIN CONJUGATE; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER TEXAS RED GLYCYLARGINYLLYSYLLYSYLARGINYLARGINYLGLUTAMINYLARGINYLARGINYLARGINYLGLYCYLTYROSY LLYSINE(FLUORESCEIN ISOTHIOCYANATE) CONJUGATE; N (2 HYDROXYPROPYL)METHACRYLAMIDE COPOLYMER TRANSACTIVATOR PROTEIN CONJUGATE; UNCLASSIFIED DRUG; HYDROXYPROPYL METHACRYLATE; METHACRYLIC ACID DERIVATIVE; TRANSACTIVATOR PROTEIN;

CARCINOMA CELL; CELL FRACTIONATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOSOL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ENERGY; HUMAN; HUMAN CELL; MACROMOLECULE; OVARY CARCINOMA; PRIORITY JOURNAL; ARTICLE; CARCINOMA; CELL CULTURE; CYTOPLASM; FEMALE; GENETIC TRANSDUCTION; METABOLISM; OVARY TUMOR;

CARCINOMA; CELL NUCLEUS; CYTOPLASM; FEMALE; GENE PRODUCTS, TAT; HUMANS; METHACRYLATES; OVARIAN NEOPLASMS; SUBCELLULAR FRACTIONS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0141955921     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00213-X     Document Type: Conference Paper

References (25)

1. Lindgren M., Hallbrink H., Prochiantz A., Langel U. Cell penetrating peptides. Trends Pharmacol. Sci. 21:(3):2000;99-103.
2. Vivès E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:(25):1997;16010-16017.
3. Schwarze S.R., Hruska K., Dowdy S.F. Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10:(7):2000;290-295.
4. Pooga M., Soomets U., Hällbring M., Valkna A., Saar K., Rezaeil K., Kahl U., Hao J.-X., Xu X.-J., Wiesenfeld-Hallin Z., Hökfelt T., Bartfai T., Langel Ü. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16:(9):1998;857-861.
5. Nagahara H., Vocero-Akbani A.M., Snyder E.L., Ho A., Latham D.G., Lissy N.A., Becker-Hapak M., Ezhevsky S.A., Dowdy S.F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4:(12):1998;1449-1452.
6. Lewin M., Carlesso N., Tung C.-H., Tang X.-W., Cory D., Scadden D.T., Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18:(4):2000;410-414.
7. Eguchi A., Akuta T., Okuyama H., Senda T., Yokoi H., Inokuchi H., Fujita S., Hayakawa T., Takeda K., Hasegawa M., Nakanishi M. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 276:(28):2001;26204-26210.
8. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:(5433):1999;1569-1572.
9. Polyakov V., Sharma V., Dahlheimer J.L., Pica C.M., Luker G.D., Piwnica-Worms D. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjug. Chem. 11:(6):2000;762-771.
10. Astriab-Fisher A., Sergueev D., Fisher M., Ramsay-Shaw B., Juliano R.L. Conjugates of antisense oligonucleotides with the Tat and Antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19:(6):2002;744-754.
11. Torchilin V.P., Rammohan R., Weissig V., Levchenko T.S. Tat peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. 98:(15):2001;8786-8791.
12. Niesner U., Halin C., Lozzi L., Günthert M., Neri P., Wunderli-Allenspach H., Zardi L., Neri D. Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides. Bioconjug. Chem. 13:(4):2002;729-736.
13. Tyagi M., Rusnati M., Presta M., Giacca M. Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276:(5):2001;3254-3261.
14. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271:(30):1996;18188-18193.
15. Putnam D., Kopeček J. Polymer conjugates with anticancer activity. Adv. Polym. Sci. 122:1995;55-123.
16. Kopeček J., Kopečková P., Minko T., Lu Z-R. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur. J. Pharm. Biopharm. 50:(1):2000;61-81.
17. J. Kopeček, P. Rejmanová, J. Strohalm, K. Ulbrich, B. Říhová, V. Chytrý, J.B. Lloyd, R. Duncan, Synthetic polymeric drugs, US Patent 5,037,883 (1998).
18. Nori A., Jensen K.D., Tijerina M., Kopečková P., Kopeček J. Tat conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells. Bioconjug. Chem. 14:2002;44-50.
19. K.D. Jensen, P. Kopečková, J.H.B. Bridge, J. Kopeček, The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells, AAPS Pharm. Sci. 3 (2001): Article 32. http://www.aapspharmsci.org/ scientificjournals/pharmsci/journal/01_32.html.
20. Ulbrich K., Subr V., Strohalm J., Plocova D., Jelinkova M., Rihova B. Polymeric drugs based on conjugates of synthetic and natural macromolecules I. Synthesis and physico-chemical characterization, J. Control. Release. 64:(1-3):2000;63-79.
21. 6 conjugates with chemotherapeutic activity in human ovarian carcinoma cells. Pharm. Res. 20:2003;728-737.
22. Omelyanenko V., Kopečková P., Gentry C., Kopěcek J. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J. Control. Release. 53:(1-3):1998;25-37.
23. Duncan R., Lloyd J.B. Pinocytosis in the rat visceral yolk sac. Effects of temperature, metabolic inhibitors and some other modifiers. Biochim. Biophys. Acta. 544:(3):1978;647-655.
24. Nori A., Jensen K.D., Kopečková P., Kopeček J. Cytoplasmic delivery and nuclear targeting of HPMA copolymer-tat conjugates to human ovarian carcinoma cells. Proc. Int. Symp. Controlled Release. Bioact. Mater. 29:2001;854-855.
25. Jensen K.D., Nori A., Tijerina M., Kopečková P., Kopeček J. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules. J. Control. Release. 87:2003;89-105.